News
-
-
PRESS RELEASE
HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
HBM Healthcare Investments almost broke even in the 2023/2024 financial year with a slight loss of CHF 1 million. Mixed portfolio performance with a 0.3% increase in NAV. Unfavourable currency developments affected results. Board proposes unchanged par value repayment of CHF 7.50 per share -
-
-
-
-
-
-
-
PRESS RELEASE
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
HBM Healthcare Investments reports CHF 156 million profit in Q4 2023/24, with NAV per share reaching CHF 248.10. Annual results show balanced performance despite challenges
